Weinan Guo

2.3k total citations · 1 hit paper
58 papers, 1.6k citations indexed

About

Weinan Guo is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Weinan Guo has authored 58 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 16 papers in Cancer Research and 15 papers in Oncology. Recurrent topics in Weinan Guo's work include Melanoma and MAPK Pathways (9 papers), melanin and skin pigmentation (9 papers) and Ferroptosis and cancer prognosis (8 papers). Weinan Guo is often cited by papers focused on Melanoma and MAPK Pathways (9 papers), melanin and skin pigmentation (9 papers) and Ferroptosis and cancer prognosis (8 papers). Weinan Guo collaborates with scholars based in China and United States. Weinan Guo's co-authors include Chunying Li, Huina Wang, Xiuli Yi, Sen Guo, Tianwen Gao, Qiong Shi, Yangzi Tian, Yuqi Yang, Gang Wang and Jinyuan Ma and has published in prestigious journals such as Clinical Cancer Research, Biochemical and Biophysical Research Communications and Free Radical Biology and Medicine.

In The Last Decade

Weinan Guo

51 papers receiving 1.6k citations

Hit Papers

Signal pathways of melanoma and targeted therapy 2021 2026 2022 2024 2021 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weinan Guo China 22 942 382 374 330 323 58 1.6k
Sen Guo China 26 998 1.1× 544 1.4× 503 1.3× 282 0.9× 495 1.5× 61 1.9k
Huina Wang China 20 726 0.8× 330 0.9× 193 0.5× 236 0.7× 137 0.4× 54 1.3k
Rui Ge China 21 656 0.7× 258 0.7× 480 1.3× 223 0.7× 242 0.7× 87 1.6k
Richard M. Niles United States 24 1.2k 1.3× 214 0.6× 177 0.5× 209 0.6× 246 0.8× 64 1.8k
Vitaly Balan United States 26 1.5k 1.6× 186 0.5× 929 2.5× 431 1.3× 122 0.4× 38 2.4k
Vinay Tergaonkar Singapore 22 1.5k 1.6× 537 1.4× 356 1.0× 572 1.7× 115 0.4× 31 2.4k
Yongxin Zou China 21 1.2k 1.2× 363 1.0× 184 0.5× 269 0.8× 81 0.3× 54 1.5k
G. Tim Bowden United States 26 1.1k 1.2× 562 1.5× 206 0.6× 568 1.7× 231 0.7× 40 2.0k
A. Pieter J. van den Heuvel United States 13 967 1.0× 335 0.9× 132 0.4× 363 1.1× 160 0.5× 14 1.4k

Countries citing papers authored by Weinan Guo

Since Specialization
Citations

This map shows the geographic impact of Weinan Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weinan Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weinan Guo more than expected).

Fields of papers citing papers by Weinan Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weinan Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weinan Guo. The network helps show where Weinan Guo may publish in the future.

Co-authorship network of co-authors of Weinan Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Weinan Guo. A scholar is included among the top collaborators of Weinan Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weinan Guo. Weinan Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Hanbin, et al.. (2025). Life Factors and Melanoma: From the Macroscopic State to the Molecular Mechanism. Advanced Science. 12(43). e01388–e01388.
2.
Li, Yuehua, Yu Liu, Yuqi Yang, et al.. (2025). PARP4 deficiency enhances sensitivity to ATM inhibitor by impairing DNA damage repair in melanoma. Cell Death Discovery. 11(1). 35–35. 2 indexed citations
5.
Yi, Xiuli, Sen Guo, Huina Wang, et al.. (2024). SIRT7 promotes mitochondrial biogenesis to render the adaptive resistance to MAPK inhibition in melanoma. Biochemical and Biophysical Research Communications. 722. 150161–150161. 1 indexed citations
6.
Wang, Huina, Xiuli Yi, Yuqi Yang, et al.. (2024). Nucleo-cytosolic acetyl-CoA drives tumor immune evasion by regulating PD-L1 in melanoma. Cell Reports. 43(12). 115015–115015. 12 indexed citations
7.
Chang, Yuqian, Pan Kang, Tingting Cui, et al.. (2023). Pharmacological inhibition of demethylzeylasteral on JAK-STAT signaling ameliorates vitiligo. Journal of Translational Medicine. 21(1). 434–434. 19 indexed citations
8.
Chen, Jianru, Weinan Guo, Tingting Cui, et al.. (2023). MIF inhibition alleviates vitiligo progression by suppressing CD8+ T cell activation and proliferation. The Journal of Pathology. 260(1). 84–96. 9 indexed citations
9.
Tian, Yangzi, Jingjing Ma, Meng‐Ru Wang, et al.. (2023). BCKDHA contributes to melanoma progression by promoting the expressions of lipogenic enzymes FASN and ACLY. Experimental Dermatology. 32(10). 1633–1643. 7 indexed citations
10.
Chen, Jianru, Tingting Cui, Qian Zhang, et al.. (2022). Th1-like Treg in vitiligo: An incompetent regulator in immune tolerance. Journal of Autoimmunity. 131. 102859–102859. 17 indexed citations
11.
Shi, Qiong, Lin Liu, Jianru Chen, et al.. (2022). Integrative Genomic Profiling Uncovers Therapeutic Targets of Acral Melanoma in Asian Populations. Clinical Cancer Research. 28(12). 2690–2703. 19 indexed citations
12.
Chen, Yuhan, et al.. (2022). Epigenetics Regulates Antitumor Immunity in Melanoma. Frontiers in Immunology. 13. 868786–868786. 17 indexed citations
13.
Wang, Huina, Xiuli Yi, Sen Guo, et al.. (2021). The XBP1‒MARCH5‒MFN2 Axis Confers Endoplasmic Reticulum Stress Resistance by Coordinating Mitochondrial Fission and Mitophagy in Melanoma. Journal of Investigative Dermatology. 141(12). 2932–2943.e12. 28 indexed citations
14.
Wang, Sijia, Xiuli Yi, Zhenjie Wu, et al.. (2021). CAMKK2 Defines Ferroptosis Sensitivity of Melanoma Cells by Regulating AMPK‒NRF2 Pathway. Journal of Investigative Dermatology. 142(1). 189–200.e8. 64 indexed citations
15.
Guo, Weinan, Kunwei Niu, Chengli Liu, et al.. (2021). Wogonin alleviates liver injury in sepsis through Nrf2‐mediated NF‐κB signalling suppression. Journal of Cellular and Molecular Medicine. 25(12). 5782–5798. 60 indexed citations
16.
Guo, Weinan, Jinyuan Ma, Yuqi Yang, et al.. (2020). ATP-Citrate Lyase Epigenetically Potentiates Oxidative Phosphorylation to Promote Melanoma Growth and Adaptive Resistance to MAPK Inhibition. Clinical Cancer Research. 26(11). 2725–2739. 55 indexed citations
17.
Guo, Weinan, Jinyuan Ma, Tianli Pei, et al.. (2018). Up‐regulated deubiquitinase USP4 plays an oncogenic role in melanoma. Journal of Cellular and Molecular Medicine. 22(5). 2944–2954. 31 indexed citations
18.
Guo, Weinan, et al.. (2018). 1195 Up-regulated deubiquitinase USP4 plays an oncogenic role in melanoma. Journal of Investigative Dermatology. 138(5). S203–S203. 5 indexed citations
19.
Guo, Weinan, Huina Wang, Yuqi Yang, et al.. (2017). Down-regulated miR-23a Contributes to the Metastasis of Cutaneous Melanoma by Promoting Autophagy. Theranostics. 7(8). 2231–2249. 85 indexed citations
20.
Guo, Sen, Weinan Guo, Shuli Li, et al.. (2016). Serum miR-16: A Potential Biomarker for Predicting Melanoma Prognosis. Journal of Investigative Dermatology. 136(5). 985–993. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026